Prevalence and risk factors for elevated anxiety symptoms and anxiety disorders in chronic kidney disease: A systematic review and meta-analysis
Top Cited Papers
- 1 March 2021
- journal article
- review article
- Published by Elsevier in General Hospital Psychiatry
- Vol. 69, 27-40
Abstract
No abstract availableKeywords
All Related Versions
This publication has 93 references indexed in Scilit:
- Problems in Cross-Cultural Use of the Hospital Anxiety and Depression Scale: “No Butterflies in the Desert”PLOS ONE, 2013
- Psychosocial factors in adults with chronic kidney disease: characteristics of pilot participants in the Tasmanian Chronic Kidney Disease studyBMC Nephrology, 2013
- Association of Posttraumatic Stress Disorder and Depression With All-Cause and Cardiovascular Disease Mortality and Hospitalization Among Hurricane Katrina Survivors With End-Stage Renal DiseaseAmerican Journal of Public Health, 2013
- Association of depression and anxiety with reduced quality of life in patients with predialysis chronic kidney diseaseInternational Journal Of Clinical Practice, 2013
- A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal diseaseKidney International, 2012
- Health-related quality of life in different stages of chronic kidney disease and at initiation of dialysis treatmentHealth and Quality of Life Outcomes, 2012
- Quality of life in patients with chronic kidney diseaseClinics, 2011
- Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studiesThe Lancet Oncology, 2011
- A Cross-Ethnic Comparison of Lifetime Prevalence Rates of Anxiety DisordersJournal of Nervous & Mental Disease, 2010
- Measuring inconsistency in meta-analysesBMJ, 2003